Skip to main content

Day: March 25, 2021

Pieridae Releases Q4 and 2020 Results

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES ORDISSEMINATION IN UNITED STATES Key Highlights:Production increased year over year from 22,397 barrels of oil equivalent per day (“boe/d”) in 2019 to 42,000 boe/d in 2020, an increase of 88% The Company managed to replace almost half of its production in 2020 while spending minimal capital The proved developed producing (“PDP”) base decline rate of the corporation is now at ~ 10% (based on 2021 PDP forecasts), one of the lowest in the industry This decline rate will provide a very reliable base production from which the Company will grow significantly in the next few years to supply the Goldboro LNG Facility in Nova Scotia Safe, reliable operations were maintained during the pandemic with historical low recordable injuries without any measurable loss of productivity during the...

Continue reading

Knight Therapeutics Reports Fourth Quarter and Year End 2020 Results

MONTREAL, March 25, 2021 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter and year ended December 31, 2020. All currency amounts are in thousands except for share and per share amounts. All currencies are Canadian unless otherwise specified. 2020 Highlights FinancialsRevenues were $199,519, an increase of $152,058 or 320% over prior year. Gross margin was $81,690 or 41% compared to $26,918 or 57% in prior year. Adjusted EBITDA1 was $16,837 compared to $2,827 in prior year. Interest income generated of $14,322 a decrease of $9,220 or 39% over prior year. Gain from strategic fund investments of $46,733, of which $16,644 was realized. Adjusted earnings1 of $28,713,...

Continue reading

Thérapeutique Knight publie ses résultats du quatrième trimestre et de fin d’année 2020

MONTRÉAL, 25 mars 2021 (GLOBE NEWSWIRE) — Thérapeutique Knight inc. (TSX : GUD) (« Knight » ou « la Société »), société pharmaceutique spécialisée panaméricaine (ex-ÉU) et chef de file, a publié aujourd’hui ses résultats financiers du quatrième trimestre clos le 31 décembre 2020 et de fin d’année 2020. Tous les montants sont exprimés en milliers à l’exception du nombre d’actions et des montants par action. Toutes les monnaies sont canadiennes, sauf indication contraire. Faits saillants de 2020 Résultats financiersLes revenus s’élèvent à 199 519 $, une hausse de 152 058 $ ou 320 % sur l’année précédente. La marge brute s’élève à 81 690 $ ou 41 % comparativement à 26 918 $ ou 57 % sur l’année précédente. Le BAIIA1 ajusté est de 16 837 $ comparativement à 2 827 $ sur l’année précédente. Les produits d’intérêts générés sont de 14...

Continue reading

PFSweb Reports Fourth Quarter and Full Year 2020 Results and Issues 2021 Outlook

ALLEN, Texas, March 25, 2021 (GLOBE NEWSWIRE) — PFSweb, Inc. (NASDAQ: PFSW), a global commerce services company, is reporting results for the fourth quarter and full year ended December 31, 2020, and is providing a financial outlook for 2021. “Our fourth quarter financial performance reflects the operational momentum we built throughout 2020, with record holiday fulfillment volumes in PFS and continued execution in LiveArea,” said Mike Willoughby, CEO of PFSweb. “We generated strong growth across both business units as we continued to experience robust eCommerce and holiday demand tailwinds. While we operated at an even larger scale than usual throughout the year—particularly during the holiday season—our teams delivered high levels of performance for our clients and their customers. We are proud to have built such a flexible and...

Continue reading

CBD for Alzheimer’s: Treatment Reduces Plaque Buildups in the Brain That Causes Disease

Denver, Colorado, March 25, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — CBD Global Sciences, Inc. (OTC: CBDNF) (CSE: CBDN) (Frankfurt:GS3), (“CBD Global” or the “Company”), is pleased to share that a recent study has revealed that CBD may be key to stopping triggers for Alzheimer’s disease, according to researchers from the Medical College of Georgia in Augusta University.  Cannabidiol, or CBD, continues to gain support as a remedy for everything from stress to bacterial infections. A new study reveals marijuana’s non-psychoactive ingredient may also be the key to stopping the triggers for Alzheimer’s disease. Researchers from the Medical College of Georgia at Augusta University say high doses of CBD restores the function of key proteins that clean up beta-amyloid plaque buildups in the brain. These clumps are one of the major...

Continue reading

Intellia Therapeutics Presents New Data on Expanded Cell Engineering Capabilities Utilizing Base Editors

CAMBRIDGE, Mass., March 25, 2021 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA) will present the first preclinical data set on its novel cytosine deaminase base editor technology at the seventh Cold Spring Harbor Laboratory (CSHL) virtual scientific meeting on Nucleic Acid Therapies. The data shows how the Company’s proprietary base editors can expand its genome editing capabilities by enabling the introduction of multiple gene knockouts simultaneously with no detectable increase in translocation above background levels. The meeting is being held virtually from March 24-26, 2021. “At Intellia, we continue to build the broadest and deepest genome editing platform for developing potentially curative treatments for severe diseases,” said Intellia President and Chief Executive Officer John Leonard, M.D. “We are quite pleased...

Continue reading

Local Community & Culture Efforts Central to nCino’s Commitments in 2021 and Beyond

WILMINGTON, N.C., March 25, 2021 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking and digital transformation solutions for the global financial services industry, today announced it is continuing to expand its efforts to positively impact the local communities in which it operates with the appointment of Zedrick Applin as the Company’s first Program Manager of Diversity, Equity, Inclusion & Community. In this role, Applin will oversee the cultivation of nCino’s inclusivity, diversity and philanthropic programs, including nCino’s community service team, nVolve. The announcement comes at a time when local communities and non-profit organizations have struggled more than ever. nCino believes the role and leadership of businesses will be critical to how communities recover in 2021 and beyond. nCino...

Continue reading

PureK Holdings Corp. ‘TRUBAR’ Plant-Based Nutrition Brand to Expand Into Canada

VANCOUVER, British Columbia, March 25, 2021 (GLOBE NEWSWIRE) — PureK Holdings Corp. (the “Company” or “PureK“) (TSX Venture: PKAN) is pleased to announce that TRU Brands Inc. (“TRU Brands“), the leading health and wellness brand and the makers of TRUBAR plant-based, clean-label snacks for women, will continue to expand its retail and online presence in Canada. TRU Brands products are already available at Costco Canada East locations in Ontario, Quebec, Nova Scotia, New Brunswick, and Newfoundland and Labrador. Over the next six months, TruBar’s Canadian momentum includes expansion commitments into approximately 800 Shoppers Drug Mart locations, as well as Rexall, Metro, and Loblaws locations. Additionally, TRU Brands expects to launch TRUWOMEN.CA, its own consumer-facing online store in Canada,...

Continue reading

Plus Products Announces Date for the Release of Audited Fourth Quarter and Full Year 2020 Results, Revises Fourth Quarter Guidance, and Provides Update Regarding Upcoming Debenture Conversion Deadline

SAN MATEO, Calif., March 25, 2021 (GLOBE NEWSWIRE) — Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”) today announced it will report its audited financial results for the fourth quarter and full year ending December 31, 2020 after markets close on April 7, 2021, revised its previously issued fourth quarter 2020 guidance, and provided an update regarding upcoming debenture conversion deadline.    Release of Audited Fourth Quarter and Full Year 2020 Results PLUS will report its audited financial results for the fourth quarter and full year 2020 after markets close on Wednesday, April 7, 2021. At 5:00 pm Eastern Time / 2:00 pm Pacific Time the same day (April 7, 2021) the Company will host a conference call and webcast to discuss the financial results and its recent corporate highlights. Jake Heimark, Co-founder...

Continue reading

Corvus Gold Reports From One Drill Hole, 38.3 Metres @ 2.15 g/t Gold, 34.7 Metres @ 4.24 g/t Gold, 35.9 Metres @ 1.77 g/t Gold, 24.8 Metres @ 2.47 g/t Gold & 40.5 Metres @ 1.45 g/t Gold, Expanding the Mother Lode Deposit, Bullfrog Gold District, Nevada

VANCOUVER, British Columbia, March 25, 2021 (GLOBE NEWSWIRE) — Corvus Gold Inc. (“Corvus” or the “Company”) – (TSX: KOR, NASDAQ: KOR) announces it has received additional results from the high-grade Central Intrusive Zone (CIZ) in the central feeder zone target of the at the Mother Lode project. Hole ML20-162CT drilled through the Main Zone returning typical width and grade (38.3m @ 2.15 g/t gold) and then went through multiple high-grade zones in the dominantly oxide lower CIZ, returning 34.7m @ 4.24 g/t gold, 35.9m @ 1.77 g/t gold, 24.8m @ 2.47 g/t gold & 8.9 g/t silver, 40.5m @ 1.45 g/t gold.  These multiple high-grade intercepts cover a total of 196.7 metres of down hole length and outline an important gold zone in the central high-grade feeder with increased potential to continue at depth. As with all intercepts...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.